- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy | 78 | dpa-AFX | Original-Research: Ikonisys SA - from Sphene Capital GmbH 23.07.2024 / 10:06 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible... ► Artikel lesen | |
| 18.07. | Ikonisys Completed a Capital Increase Through a Private Placement | 256 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 09.07. | Ikonisys Announces that Hospitex International Signed Supply Contracts in Italy Marking Growth Potential for the Group | 238 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a leading company in early and accurate cancer diagnosis through cutting-edge and fully automated solutions for medical analysis laboratories... ► Artikel lesen | |
| 08.07. | Ikonisys SA: Ikonisys: The 2023 Annual Report Is Now Available | 208 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a leading company in early and accurate cancer diagnosis through cutting-edge and fully automated solutions for medical analysis laboratories... ► Artikel lesen | |
| 02.07. | Ikonisys SA: Ikonisys Reports Its Full-Year Financial Results for 2023 and Provides an Update on Its Latest Developments | 236 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 11.06. | Ikonisys and Ulisse Biomed Announce Strategic Partnership to Support Innovation in Cancer Diagnostics | 323 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 03.06. | Ikonisys SA: Ikonisys Closes Capital Increase Through a Private Placement to Further Accelerate Its Commercial Development | 286 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 30.05. | Ikonisys SA: Ikonisys Introduces New Website to Highlight Advantages of FISH Technology and Total Automation in Healthcare | 209 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 24.05. | Ikonisys SA: Ikonisys Announces Postponement of the Publication of Its 2023 Annual Financial Report | 242 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 21.05. | Ikonisys: Hospitex Expands in Ukraine through a Partnership with Diagen LLC to Fight Cancer | 229 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 15.05. | Ikonisys SA: Ikonisys: Hospitex to Obtain International Patent for the BLOCKfast Cyto-Inclusion Kit | 314 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 30.04. | Ikonisys SA: Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report | 276 | Business Wire | Regulatory News:
Ikonisys SA (ISIN Code: FR00140048X2 Ticker: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique and fully-automated solution... ► Artikel lesen | |
| 29.02. | Ikonisys SA: Ikonisys: Hospitex International to Partner With Allianz Value for First Large-Scale Screening Program Dedicated to Urinary Tract Oncology Diagnostics in Italy | 386 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 19.02. | Ikonisys SA: Ikonisys Announces That Hospitex International Won the Public Tender of the Prestigious U.O.C. Pathological Anatomy of Ragusa | 330 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 06.02. | Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy | 206 | dpa-AFX | Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:... ► Artikel lesen | |
| 02.01. | Ikonisys SA: Ikonisys: New Production Record for Hospitex International | 438 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 28.12.23 | Ikonisys Announces the Completion of a Private Placement to Speed up Growth Following Recent Pivotal Deals | 624 | Business Wire | Private placement of €1m, conducted with a restricted group of Italian private and institutional investors Following recent announcements, these funds will enable Ikonisys to speed up growth... ► Artikel lesen | |
| 15.12.23 | Ikonisys SA: Ikonisys Announces a Partnership Between Hospitex International and the Pathologists Beyond Borders Association | 326 | Business Wire | Regulatory News:
Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis... ► Artikel lesen | |
| 30.11.23 | Ikonisys SA: Ikonisys to Acquire Hospitex International and Become an Integrated Cancer Diagnostic Leader | 380 | Business Wire | Hospitex, a world leader in Thin Layer Cytology and Cancer Diagnostics, providing a competitive solution based on a patented and cutting-edge technology, the Nephelometric Smart Technology (NST)... ► Artikel lesen | |
| 01.11.23 | Original-Research: Ikonisys SA (von Sphene Capital GmbH): Buy | 314 | dpa-AFX | Original-Research: Ikonisys SA - von Sphene Capital GmbH Einstufung von Sphene Capital GmbH zu Ikonisys SA Unternehmen: Ikonisys SA ISIN: FR00140048X2 Anlass der Studie: Update Report Empfehlung:... ► Artikel lesen |
Seite:
1 2 Weiter >>
28 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 31,860 | 0,00 % | Fresenius: Dank defensiver Qualitäten zum Outperformer | Die Aktie von Fresenius hat sich zuletzt als einer der Outperformer im DAX entpuppt. Charttechnisch sieht es jetzt spannend aus. Der Kurs steht direkt vor einer wichtigen Hürde und könnte mittelfristig... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 53,30 | +0,38 % | JPMORGAN stuft Siemens Healthineers auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Siemens Healthineers vor Quartalszahlen auf "Overweight" mit einem Kursziel von 72,90 Euro belassen. Seine Prognosen für Umsatz... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 37,180 | -1,51 % | Kurs der FMC-Aktie verharrt auf Vortags-Niveau (52,8534 €) | Der Kurs der dem Anteilsschein von FMC kommt kaum von der Stelle. Die Aktie notiert aktuell bei 57,55 US-Dollar. Kaum verändert im Vergleich zu der Schlussnotierung vom Vortag zeigt sich gegenwärtig... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 61,70 | +1,98 % | RBC stuft CARL ZEISS MEDITEC AG auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Carl Zeiss Meditec auf "Outperform" mit einem Kursziel von 85 Euro belassen. Bei den anstehenden Zahlen der europäischen Medizintechnik-Unternehmen... ► Artikel lesen | |
| GERRESHEIMER | 93,75 | +1,46 % | JPMORGAN stuft GERRESHEIMER AG auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Gerresheimer auf "Overweight" mit einem Kursziel von 121,80 Euro belassen. Dass der US-Branchenkollege West Pharma enttäuschende Quartalszahlen... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 61,85 | -3,96 % | Procept Biorobotics: Point72 Europe London LLP hat 123800 Aktien dazugekauft! | Medizintechnik-Unternehmen mit 58%-Halbjahresrallye bei Procept Biorobotics (PRCT) Immer noch rote Zahlen, aber viel Potenzial! Procept Biorobotics (PRCT) - ISIN US74276L1052 Rückblick: Das Medizintechnik-Unternehmen... ► Artikel lesen | |
| CAREMAX | 6,420 | +13,83 % | HotStocks USA: +27 % bei CareMax, - 28 % bei MaxLinear | ||
| BRIGHTSPRING HEALTH SERVICES | 12,330 | +1,99 % | BrightSpring Health Services, Inc.: BrightSpring Health Services Announces Definitive Agreement to Acquire Haven, Expanding Its Hospice Services into the CON State of Florida | LOUISVILLE, Ky., June 24, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for... ► Artikel lesen | |
| PROGYNY | 29,140 | +1,89 % | Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report | ||
| TEMPUS AI | 41,920 | +4,75 % | wO Börsenlounge: Eli Lilly | Tempus AI | BP & Rechenzentrenperle aus Schweden | Rechenzentren schießen wie Pilze aus dem Boden. Die Nachfrage ist groß, da KI-Modelle schließlich richtig viel Rechenpower brauchen. Die üblichen Verdächtigen sind wieder angesprungen. Eine Perle aus... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,930 | -4,59 % | Critical Insights From Alignment Healthcare Analyst Ratings: What You Need To Know | ||
| RXSIGHT | 44,500 | -1,77 % | RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024 | ||
| GENEDX | 33,530 | +2,48 % | GeneDx Holdings Corp.: GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients | -- New integration to streamline access for health systems and improve provider and patient journeys using Epic for electronic connections -- -- Increases commercial footprint and focus on accelerating... ► Artikel lesen | |
| DEXCOM | 58,84 | -0,15 % | Kaum Impulse für die Dexcom-Aktie (102,3438 €) | Im US-amerikanischen Wertpapierhandel ist das Wertpapier von Dexcom gegenwärtig unauffällig. Die Aktie notiert derzeit bei 111,35 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Dexcom.... ► Artikel lesen | |
| ATRICURE | 22,120 | -5,99 % | AtriCure (ATRC) Gains China Approval for AtriClip LAA System |
IKONISYS gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,390 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu IKONISYS finden Sie auf Wallstreet Online.
